The CAR-T (Chimeric Antigen Receptor T-cell) therapy market has been revolutionizing cancer treatment, offering a breakthrough approach to battling certain types of cancers, particularly hematological cancers such as leukemia and lymphoma. By genetically modifying a patient’s T-cells, th